Integrating compression therapy into heart failure and lymphoedema management

Area of Science:

• Cardiology
• Vascular Medicine
• Oncology

Background:

• Heart failure (HF) and lymphoedema frequently coexist, impacting patient quality of life and necessitating complex management strategies.
• HF affects approximately 1 million people in the UK, while lymphoedema impacts 4-29 per 1000 individuals, predominantly older adults.

Purpose of the Study:

• To examine the integration of compression therapy (CT) for lymphoedema management in patients with coexisting heart failure (HF).
• To assess the safety and efficacy of combined treatment approaches.

Main Methods:

• Review of existing evidence on the use of CT in patients with both HF and lymphoedema.
• Emphasis on multidisciplinary collaboration and adherence to clinical guidelines.

Main Results:

• Evidence suggests that CT can be safely administered to stable HF patients for lymphoedema management.
• Careful management and a holistic, patient-centred approach are crucial for successful integration.
• This integrated approach shows potential for improving overall treatment outcomes and patient wellbeing.

Conclusions:

• The integration of CT for lymphoedema in HF patients is feasible with careful planning and multidisciplinary input.
• A patient-focused and comprehensive care model is essential for optimizing treatment decisions.
• Collaboration among healthcare professionals and patients is key to navigating the complexities of coexisting HF and lymphoedema.